SCHEMBL5777962

SCHEMBL5777962

C[S+]([O-])c1nccc(-c2sc(N)nc2-c2ccccc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
MAPT P10636 5/20 0.52
CYP1A2 P05177 2/20 0.52
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
KDM4E B2RXH2 3/20 0.48
GAA P10253 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPK1 P28482 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
PKM P14618 1/20 0.44
HTT P42858 1/20 0.44
LMNA P02545 2/20 0.43
TGFBR1 P36897 8/20 0.43
XBP1 P17861 1/20 0.40
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5819549 0.88 TGFBR1 (0.55) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5812694 0.86 TGFBR1 (0.59) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5780175 0.85 ADORA2A (0.36) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL15653814 0.80 CDK4 (0.50) ALDH1A1MAPTKDM4EGAAMAPK1
SCHEMBL27997668 0.78 AURKA (0.50) MAPTKDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL5781568 0.78 KMT2A (0.47) MAPTKMT2A
SCHEMBL24760755 0.78 ALDH1A1 (0.59) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL5779376 0.77 ALDH1A1 (0.55) ALDH1A1MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL6840009 0.76 MEN1 (0.41) ALDH1A1MAPTMEN1KMT2APKM
SCHEMBL5822172 0.74 PTGS2 (0.41) TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105517-B2 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. (US) 2006-09-12 US disclosed
EP-1434776-B1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2006-06-28 EP disclosed
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents SYNGENTA CROP PROTECTION, INC. 2005-02-17 US disclosed
EP-1434776-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS Syngenta Participations AG (CH) 2004-07-07 EP disclosed
WO-2003029249-A1 THIAZOLYL SUBSTITUTED AMINOPYRIMIDINES AS PLANT PROTECTION AGENTS SYNGENTA PARTICIPATIONS AG (CH) 2003-04-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038059-A1 Thiazolyl substituted aminopyrimidines as plant protection agents RARS2, CYP4X1, QDPR ALDH1A1 243/4885MAPT 1623/4885CYP1A2 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.